Thoracic Research and Practice
Case report

Nebulized Lidocaine as an Alternative Therapy for Reactive Airway Dysfunction Syndrome

1.

Department of Allergy and Immunology, Koç University Faculty of Medicine, İstanbul, Turkey

2.

Department of Chest Diseases, İstanbul University Faculty of Medicine, İstanbul, Turkey

Thorac Res Pract 2016; 17: 82-83
DOI: 10.5578/ttj.17.2.017
Read: 1662 Downloads: 1168 Published: 18 July 2019

Abstract

Reactive airway dysfunction syndrome (RADS) is a variant of irritant-induced asthma that develops in subjects without prior bronchoobstructive disease, following high-level exposure to nonimmunogenic irritants. Recommended maintenance treatment for RADS is not different from asthma. But in some cases, severe symptoms may persist despite the bronchodilators and corticosteroids.We describe the first case of a patient with RADS, unresponsive to all medical agents, who was successfully treated with lidocaine.

Files
EISSN 2979-9139